Product Information
LAMIVUDINE 150 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.4602 per EA under NDC 00904658304. Its NADAC has been published 453 times since May 31, 2017.
Strength
150 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904658304
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA091606On Market Since
12/2/2011
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 150 MG TABLET has been published 453 times since May 31, 2017, and over the history we have for it it has declined 70.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4602 per EA |
|---|---|
| All-time high | $1.5942 (Jan 10, 2018) |
| All-time low | $0.4126 (Oct 22, 2025) |
| 52-week high | $0.5088 |
| 52-week low | $0.4126 |
| Median price | $0.8913 |
| Average price | $0.8945 |
| Largest weekly change | +54.1% (May 22, 2019) |
| Weeks tracked | 453 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Major Pharmaceuticals, is $0.4602 per EA (NDC 00904658304), effective Jun 24, 2026.
How has the price of LAMIVUDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 70.0%. It has been tracked across 453 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?
Since May 31, 2017, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.4126 (Oct 22, 2025) to a high of $1.5942 (Jan 10, 2018), with a median of $0.8913 per EA.
Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as LAMIVUDINE 150 MG TABLET, but none are currently priced below it.
Who manufactures LAMIVUDINE 150 MG TABLET?
LAMIVUDINE 150 MG TABLET (NDC 00904658304) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification